Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

888
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
888
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

771
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
771
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

979
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
979
Vaccinations01:51

Vaccinations

44.4K
Overview
44.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming Aromatic Camptothecins into TOP1 Degraders via Synergistic Hydrophobic Tagging and Supramolecular Assembly.

Journal of the American Chemical Society·2026
Same author

Author Correction: DNA nanodevices detect an acidic nanolayer on the lysosomal surface.

Nature cell biology·2026
Same author

Receptor-Tethered Cytosolic Modulators Enable Spatial Control of Cell Signaling Specificity.

ACS nano·2026
Same author

RBM38 Regulates HORMAD1 Splicing to Enhances MEK Inhibitor Sensitivity in Breast Cancer.

RNA (New York, N.Y.)·2026
Same author

Covalent Photo-Aptamer Tagging (CPAT) for Single-Cell Multiplexing and Chemical Transcriptomic Screens.

Analytical chemistry·2026
Same author

Modular nucleic acid-based construct for delivery of immunostimulatory agonists and oncogene-silencing oligonucleotides in tumours.

Nature biomedical engineering·2026

Related Experiment Video

Updated: Jun 22, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K

Stimuli-Responsive mRNA Vaccines to Induce Robust CD8+ T Cell Response via ROS-Mediated Innate Immunity Boosting.

Linying Dong1,2, Xuqian Deng2,3, Yan Li2,3

  • 1Medical School, Faculty of Medicine, Tianjin University, Tianjin 300072, China.

Journal of the American Chemical Society
|July 2, 2024
PubMed
Summary
This summary is machine-generated.

New stimuli-responsive mRNA vaccines effectively boost antitumor immunity by releasing mRNA and increasing reactive oxygen species (ROS) for enhanced T cell responses against cancer.

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K

Related Experiment Videos

Last Updated: Jun 22, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K

Area of Science:

  • Immunology and Vaccine Development
  • Nanotechnology and Biomaterials

Background:

  • Messenger RNA (mRNA) vaccines are significant for contagion prevention and cancer immunotherapy.
  • Harnessing innate immunity to stimulate robust adaptive immune protection for vaccines remains challenging.

Purpose of the Study:

  • To synthesize stimuli-responsive bivalent ionizable lipids (srBiv iLPs) for enhanced mRNA vaccine delivery.
  • To leverage physiological cues for rapid lipid degradation, improved mRNA translation, and ROS-mediated antitumor immunity.

Main Methods:

  • Synthesized srBiv iLPs with molecular blocks responsive to various physiological stimuli (esterase, H2O2, etc.).
  • Administered esterase-responsive vaccine (eBiv-mVac) and tracked its internalization, degradation, and immune response.
  • Combined vaccination strategy with immune checkpoint blockade to assess synergistic effects.

Main Results:

  • eBiv-mVac rapidly degraded in esterase-rich cells, releasing mRNA and generating reactive oxygen species (ROS).
  • This process broadly activated innate immunity, significantly boosting antigen-specific CD8+ T cell responses and tumor infiltration.
  • Combination therapy with immune checkpoint blockade demonstrated synergistic effects, leading to potent systemic antitumor efficacy and prolonged survival.

Conclusions:

  • Stimuli-responsive mRNA delivery platforms can effectively orchestrate innate and adaptive immunity for cancer control.
  • The developed platform shows promise for potent cancer vaccines and precise gene/protein delivery applications.
  • This approach represents a paradigm shift in designing advanced vaccines and therapeutic delivery systems.